Acute Hepatic Porphyria Drug and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Acute Hepatic Porphyria Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Acute Hepatic Porphyria Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Acute Hepatic Porphyria Drug Overall Market Size
2.1 Global Acute Hepatic Porphyria Drug Market Size: 2021 VS 2028
2.2 Global Acute Hepatic Porphyria Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Acute Hepatic Porphyria Drug Players in Global Market
3.2 Top Global Acute Hepatic Porphyria Drug Companies Ranked by Revenue
3.3 Global Acute Hepatic Porphyria Drug Revenue by Companies
3.4 Top 3 and Top 5 Acute Hepatic Porphyria Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Acute Hepatic Porphyria Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acute Hepatic Porphyria Drug Players in Global Market
3.6.1 List of Global Tier 1 Acute Hepatic Porphyria Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Acute Hepatic Porphyria Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Acute Hepatic Porphyria Drug Market Size Markets, 2021 & 2028
4.1.2 350 Mg
4.1.3 313 Mg
4.2 By Type - Global Acute Hepatic Porphyria Drug Revenue & Forecasts
4.2.1 By Type - Global Acute Hepatic Porphyria Drug Revenue, 2017-2022
4.2.2 By Type - Global Acute Hepatic Porphyria Drug Revenue, 2023-2028
4.2.3 By Type - Global Acute Hepatic Porphyria Drug Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Acute Hepatic Porphyria Drug Market Size, 2021 & 2028
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacy
5.1.5 Others
5.2 By Application - Global Acute Hepatic Porphyria Drug Revenue & Forecasts
5.2.1 By Application - Global Acute Hepatic Porphyria Drug Revenue, 2017-2022
5.2.2 By Application - Global Acute Hepatic Porphyria Drug Revenue, 2023-2028
5.2.3 By Application - Global Acute Hepatic Porphyria Drug Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Acute Hepatic Porphyria Drug Market Size, 2021 & 2028
6.2 By Region - Global Acute Hepatic Porphyria Drug Revenue & Forecasts
6.2.1 By Region - Global Acute Hepatic Porphyria Drug Revenue, 2017-2022
6.2.2 By Region - Global Acute Hepatic Porphyria Drug Revenue, 2023-2028
6.2.3 By Region - Global Acute Hepatic Porphyria Drug Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Acute Hepatic Porphyria Drug Revenue, 2017-2028
6.3.2 US Acute Hepatic Porphyria Drug Market Size, 2017-2028
6.3.3 Canada Acute Hepatic Porphyria Drug Market Size, 2017-2028
6.3.4 Mexico Acute Hepatic Porphyria Drug Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Acute Hepatic Porphyria Drug Revenue, 2017-2028
6.4.2 Germany Acute Hepatic Porphyria Drug Market Size, 2017-2028
6.4.3 France Acute Hepatic Porphyria Drug Market Size, 2017-2028
6.4.4 U.K. Acute Hepatic Porphyria Drug Market Size, 2017-2028
6.4.5 Italy Acute Hepatic Porphyria Drug Market Size, 2017-2028
6.4.6 Russia Acute Hepatic Porphyria Drug Market Size, 2017-2028
6.4.7 Nordic Countries Acute Hepatic Porphyria Drug Market Size, 2017-2028
6.4.8 Benelux Acute Hepatic Porphyria Drug Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Acute Hepatic Porphyria Drug Revenue, 2017-2028
6.5.2 China Acute Hepatic Porphyria Drug Market Size, 2017-2028
6.5.3 Japan Acute Hepatic Porphyria Drug Market Size, 2017-2028
6.5.4 South Korea Acute Hepatic Porphyria Drug Market Size, 2017-2028
6.5.5 Southeast Asia Acute Hepatic Porphyria Drug Market Size, 2017-2028
6.5.6 India Acute Hepatic Porphyria Drug Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Acute Hepatic Porphyria Drug Revenue, 2017-2028
6.6.2 Brazil Acute Hepatic Porphyria Drug Market Size, 2017-2028
6.6.3 Argentina Acute Hepatic Porphyria Drug Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Acute Hepatic Porphyria Drug Revenue, 2017-2028
6.7.2 Turkey Acute Hepatic Porphyria Drug Market Size, 2017-2028
6.7.3 Israel Acute Hepatic Porphyria Drug Market Size, 2017-2028
6.7.4 Saudi Arabia Acute Hepatic Porphyria Drug Market Size, 2017-2028
6.7.5 UAE Acute Hepatic Porphyria Drug Market Size, 2017-2028
7 Players Profiles
7.1 Alnylam Pharmaceuticals
7.1.1 Alnylam Pharmaceuticals Corporate Summary
7.1.2 Alnylam Pharmaceuticals Business Overview
7.1.3 Alnylam Pharmaceuticals Acute Hepatic Porphyria Drug Major Product Offerings
7.1.4 Alnylam Pharmaceuticals Acute Hepatic Porphyria Drug Revenue in Global Market (2017-2022)
7.1.5 Alnylam Pharmaceuticals Key News
7.2 Recordati Rare Diseases
7.2.1 Recordati Rare Diseases Corporate Summary
7.2.2 Recordati Rare Diseases Business Overview
7.2.3 Recordati Rare Diseases Acute Hepatic Porphyria Drug Major Product Offerings
7.2.4 Recordati Rare Diseases Acute Hepatic Porphyria Drug Revenue in Global Market (2017-2022)
7.2.5 Recordati Rare Diseases Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Acute Hepatic Porphyria Drug Market Opportunities & Trends in Global Market
Table 2. Acute Hepatic Porphyria Drug Market Drivers in Global Market
Table 3. Acute Hepatic Porphyria Drug Market Restraints in Global Market
Table 4. Key Players of Acute Hepatic Porphyria Drug in Global Market
Table 5. Top Acute Hepatic Porphyria Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Acute Hepatic Porphyria Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Acute Hepatic Porphyria Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Acute Hepatic Porphyria Drug Product Type
Table 9. List of Global Tier 1 Acute Hepatic Porphyria Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acute Hepatic Porphyria Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Acute Hepatic Porphyria Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Acute Hepatic Porphyria Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Acute Hepatic Porphyria Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Acute Hepatic Porphyria Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Acute Hepatic Porphyria Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Acute Hepatic Porphyria Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2023-2028
Table 30. Alnylam Pharmaceuticals Corporate Summary
Table 31. Alnylam Pharmaceuticals Acute Hepatic Porphyria Drug Product Offerings
Table 32. Alnylam Pharmaceuticals Acute Hepatic Porphyria Drug Revenue (US$, Mn), (2017-2022)
Table 33. Recordati Rare Diseases Corporate Summary
Table 34. Recordati Rare Diseases Acute Hepatic Porphyria Drug Product Offerings
Table 35. Recordati Rare Diseases Acute Hepatic Porphyria Drug Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Acute Hepatic Porphyria Drug Segment by Type in 2021
Figure 2. Acute Hepatic Porphyria Drug Segment by Application in 2021
Figure 3. Global Acute Hepatic Porphyria Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Acute Hepatic Porphyria Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Acute Hepatic Porphyria Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Acute Hepatic Porphyria Drug Revenue in 2021
Figure 8. By Type - Global Acute Hepatic Porphyria Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Acute Hepatic Porphyria Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Acute Hepatic Porphyria Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Acute Hepatic Porphyria Drug Revenue Market Share, 2017-2028
Figure 12. US Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Acute Hepatic Porphyria Drug Revenue Market Share, 2017-2028
Figure 16. Germany Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Acute Hepatic Porphyria Drug Revenue Market Share, 2017-2028
Figure 24. China Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Acute Hepatic Porphyria Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Acute Hepatic Porphyria Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Acute Hepatic Porphyria Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Alnylam Pharmaceuticals Acute Hepatic Porphyria Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Recordati Rare Diseases Acute Hepatic Porphyria Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
